Thai PBS Thai PBS
Mahidol-GPO’s human trials of its COVID-19 vaccine show promising results

Mahidol-GPO’s human trials of its COVID-19 vaccine show promising results

13 Sept 23:17 Key points summarised by AI
  • Mahidol-GPO's HXP-GPOVac COVID-19 vaccine candidate demonstrated a promising immune response in its initial Phase 1 human trials.
  • All 210 volunteers in the first phase remained healthy, with laboratory tests confirming an impressive immune response comparable to international results.
  • The trials are progressing, with Phase 2 scheduled for August involving 250 volunteers to select optimal vaccine formulae, followed by a large-scale Phase 3.
Read full article
Thai PBS World 1/1
Skip > Skip >